5 Key Takeaways

• 1

  Next-generation sequencing (NGS) enhances traditional newborn screening by identifying serious genetic conditions that biochemical tests may miss.

• 2

  Genomic newborn screening (gNBS) can detect disease-causing genetic variants, enabling earlier identification of inherited conditions.

• 3

  Pilot programs show gNBS identifies actionable genetic diseases missed by standard screening, including immunodeficiencies and neuromuscular disorders.

• 4

  Current gNBS initiatives focus on well-characterized conditions to minimize ambiguous results and reduce parental anxiety.

• 5

  Advancements in rapid sequencing pipelines are reducing turnaround times, with results now available in about 7 days for critically ill infants.